Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$428,614,218
-$367,224,474 QoQ
Shares Held
17,799,594
-37.2% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#34
of 2,816 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $21,591,255,986 across 16 Drug Manufacturers - General names. PFE ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,590,218 | $5,505,645,627 | |
| 2 | ABBV |
AbbVie Inc.
|
19,925,232 | $5,013,985,374 | |
| 3 | AZN |
Astrazeneca PLC
|
16,511,727 | $3,130,953,667 | |
| 4 | JNJ |
Johnson & Johnson
|
10,086,602 | $2,561,694,303 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,548,585 | $2,511,993,169 | |
| 6 | NVO |
Novo Nordisk A S
|
13,041,109 | $625,190,761 | |
| 7 | NVS |
Novartis AG
|
3,251,281 | $509,540,755 | |
| 8 | AMGN |
Amgen Inc
|
1,365,550 | $494,492,960 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $428,614,218 | 17,799,594 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $795,838,692 | 28,341,834 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $626,591,737 | 25,164,327 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $638,787,365 | 25,070,148 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $411,140,959 | 16,961,261 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $414,355,948 | 16,351,853 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $435,195,169 | 16,403,889 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $475,461,158 | 16,429,204 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $710,772,802 | 25,402,888 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $551,668,858 | 19,879,959 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $592,371,520 | 20,575,600 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $702,736,564 | 21,185,908 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $810,599,018 | 22,099,210 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $951,158,074 | 23,312,698 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $850,639,539 | 16,601,084 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $878,903,405 | 20,084,630 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,081,101,457 | 20,619,902 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,367,147,228 | 26,408,098 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,609,503,584 | 44,191,424 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,977,612,313 | 45,980,291 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,398,392,983 | 35,709,729 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $962,022,722 | 26,553,208 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $700,140,368 | 19,020,385 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $853,241,857 | 23,249,120 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,110,764,064 | 33,968,285 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $928,716,115 | 28,453,351 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||